Aptivus/Ritonavir Capsules


Indications and Reactions:

Role Indications Reactions
Primary
Hiv Infection 66.5%
Acquired Immunodeficiency Syndrome 6.1%
Antiretroviral Therapy 5.5%
Antiviral Treatment 3.8%
Convulsion 3.4%
Gestational Diabetes 2.8%
Chronic Obstructive Pulmonary Disease 2.5%
Medical Diet 1.7%
Prophylaxis 1.3%
Allergy Prophylaxis 0.8%
Antifungal Prophylaxis 0.8%
Gastrooesophageal Reflux Disease 0.8%
Hypertension 0.8%
Agoraphobia 0.4%
Analgesic Effect 0.4%
Anticoagulant Therapy 0.4%
Blood Testosterone Decreased 0.4%
Cryptococcosis 0.4%
Drug Resistance 0.4%
Herpes Simplex 0.4%
Death 14.3%
Haemorrhage Intracranial 12.6%
Gastrointestinal Malformation 9.2%
Liver Function Test Abnormal 8.4%
Liver Disorder 6.7%
Aspartate Aminotransferase Increased 5.0%
Hepatitis 5.0%
Viral Load Increased 5.0%
Mental Status Changes 4.2%
Subcutaneous Abscess 4.2%
Hepatotoxicity 3.4%
Rash 3.4%
Hypersensitivity 2.5%
Hypertension 2.5%
Jaundice 2.5%
Loss Of Consciousness 2.5%
Meningitis Cryptococcal 2.5%
Transaminases Increased 2.5%
Adverse Event 1.7%
Central Nervous System Lymphoma 1.7%
Secondary
Hiv Infection 69.2%
Acquired Immunodeficiency Syndrome 19.2%
Convulsion 7.7%
Drug Resistance 3.8%
Haemorrhage Intracranial 20.0%
Hypertension 20.0%
Sudden Death 13.3%
White Blood Cell Count Decreased 13.3%
Fatigue 6.7%
Hydrocephalus 6.7%
Refusal Of Treatment By Patient 6.7%
Toxoplasmosis 6.7%
Treatment Noncompliance 6.7%

Drug Data